Gary Jacob’s rise to CEO of a Nasdaq-listed biotech company started with chemistry classes in Benton Hall and a willingness to take risks and embrace change.
LATEST IN IBS-C
1969 alumnus’ journey to CEO of Synergy Pharmaceuticals, FDA-approved drug TRULANCE starts with UMSL chemistry degree
Gary Jacob’s rise to CEO of a Nasdaq-listed biotech company started with chemistry classes in Benton Hall and a willingness to take risks and embrace change.
1969 alumnus’ journey to CEO of Synergy Pharmaceuticals, FDA-approved drug TRULANCE starts with UMSL chemistry degree
Gary Jacob’s rise to CEO of a Nasdaq-listed biotech company started with chemistry classes in Benton Hall and a willingness to take risks and embrace change.
UMSL political scientists share research on vote centers with election officials across the country during Books and Ballots Series webinar
Anita Manion and David Kimball were panelists in a webinar cosponsored by the nonpartisan Center for Election Innovation and Research and the Elections Group.
MORE IN IBS-C
LATEST NEWS
- UMSL political scientists share research on vote centers with election officials across the country during Books and Ballots Series webinar
- DNP graduate Emily Leone builds on passion for women’s health and advocacy
- Over too soon: Top-seeded UMSL volleyball team falls in opening round of NCAA Tournament to end magical season
- Entrepreneurship and Innovation Center awarded $75,000 Small Business Administration grant
- UMSL students earn real-world entrepreneurial experience in expanded Anchor Accelerator internship program
- UMSL women’s soccer team tops Maryville to win Midwest Region title
- UMSL community comes together for Lakota toy drive
- Assistant Professor Tessa Garcia-Collart leads immersive two-day seminar in Finland
- Marcia Countryman honored as MOCPA’s 2025 Outstanding Educator of the Year
- GivingTuesday aims to strengthen Triton Pantry’s support for UMSL students
